In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes

References

• Aggarwal D, Gautam D, Sharma M, Singla SK. 2016. Bergenin attenuates renal injury by reversing mitochondrial dysfunction in ethylene glycol induced hyperoxaluric rat model. Eur J Pharmacol. 791:611–621.
   PubMed Web of Science ®Google Scholar
• Ahmed F, Urooj A. 2012. Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity. Pharm Biol. 50:468–473.
   PubMed Web of Science ®Google Scholar
• Bajracharya GB. 2015. Diversity, pharmacology and synthesis of bergenin and its derivatives: potential materials for therapeutic usages. Fitoterapia. 101:133–152.
   PubMed Web of Science ®Google Scholar
• Bedada SK, Neerati P. 2018. The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects. Eur J Clin Pharmacol. 74:91–97.
   PubMed Web of Science ®Google Scholar
• Bessong PO, Obi CL, Andreola ML, Rojas LB, Pouysegu L, Igumbor E, Meyer JJ, Quideau S, Litvak S. 2005. Evaluation of selected South African medicinal plants for inhibitory properties against human immunodeficiency virus type 1 reverse transcriptase and integrase. J Ethnopharmacol. 99:83–91.
   PubMed Web of Science ®Google Scholar
• Ericsson T, Sundell J, Torkelsson A, Hoffmann KJ, Ashton M. 2014. Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies. Xenobiotica. 44:615–626.
   PubMed Web of Science ®Google Scholar
• Hu X, Huang W, Yang Y. 2015. Cytochrome P450 isoenzymes in rat and human liver microsomes associate with the metabolism of total coumarins in Fructus Cnidii. Eur J Drug Metab Pharmacokinet. 40:373–377.
   PubMed Web of Science ®Google Scholar
• Ito K, Iwatsubo T, Kanamitsu S, Nakajima Y, Sugiyama Y. 1998. Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport. Annu Rev Pharmacol Toxicol. 38:461–499.
   PubMed Web of Science ®Google Scholar
• Jeong HU, Kong TY, Kwon SS, Hong SW, Yeon SH, Choi JH, Lee JY, Cho YY, Lee HS. 2013. Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes. Molecules. 18:10681–10693.
   PubMed Web of Science ®Google Scholar
• Lang J, Li W, Zhao J, Wang K, Chen D. 2017. Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes. Xenobiotica. 47:849–855.
   PubMed Web of Science ®Google Scholar
• Lee SY, Lee JY, Kang W, Kwon KI, Park SK, Oh SJ, Ma JY, Kim SK. 2013. Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang. Food Chem Toxicol. 51:343–349.
   PubMed Web of Science ®Google Scholar
• Li AP. 2001. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov Today. 6:357–366.
   PubMed Web of Science ®Google Scholar
• Li BH, Wu JD, Li XL. 2013. LC-MS/MS determination and pharmacokinetic study of bergenin, the main bioactive component of Bergenia purpurascens after oral administration in rats. J Pharm Anal. 3:229–234.
   PubMedGoogle Scholar
• Liu B, Wang M, Wang X. 2018. Phytochemical analysis and antibacterial activity of methanolic extract of Bergenia purpurascens against common respiratory infection causing bacterial species in vitro and in neonatal rats. Microb Pathog. 117:315–319.
   PubMed Web of Science ®Google Scholar
• Liu T, Qian G, Wang W, Zhang Y. 2015. Molecular docking to understand the metabolic behavior of GNF-351 by CYP3A4 and its potential drug-drug interaction with ketoconazole. Eur J Drug Metab Pharmacokinet. 40:235–238.
   PubMed Web of Science ®Google Scholar
• Meng Q, Liu K. 2014. Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters. Curr Drug Metab. 15:791–807.
   PubMed Web of Science ®Google Scholar
• Nowack R. 2008. Cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John's Wort - and beyond! Nephrology. 13:337–347.
   PubMed Web of Science ®Google Scholar
• Pan RH, He HM, Dai Y, Xia YF. 2016. Comparative pharmacokinetics of bergenin, a main active constituent of Saxifraga stolonifera Curt., in normal and hepatic injury rats after oral administration. Chin J Nat Med. 14:776–782.
   PubMed Web of Science ®Google Scholar
• Pandey R, Kumar B, Meena B, Srivastava M, Mishra T, Tiwari V, Pal M, Nair NK, Upreti DK, Rana TS. 2017. Major bioactive phenolics in Bergenia species from the Indian Himalayan region: method development, validation and quantitative estimation using UHPLC-QqQLIT-MS/MS. PLoS One. 12:e0180950.
   PubMed Web of Science ®Google Scholar
• Pandit S, Mukherjee PK, Ponnusankar S, Venkatesh M, Srikanth N. 2011. Metabolism mediated interaction of α-asarone and Acorus calamus with CYP3A4 and CYP2D6. Fitoterapia. 82:369–374.
   PubMed Web of Science ®Google Scholar
• Peng Y, Wu H, Zhang X, Zhang F, Qi H, Zhong Y, Wang Y, Sang H, Wang G, Sun J. 2015. A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug-drug interaction evaluation. Xenobiotica. 45:961–977.
   PubMed Web of Science ®Google Scholar
• Qi XY, Liang SC, Ge GB, Liu Y, Dong PP, Zhang JW, Wang AX, Hou J, Zhu LL, Yang L, et al. 2013. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol. 56:392–397.
   PubMed Web of Science ®Google Scholar
• Shi X, Li X, He J, Han Y, Li S, Zou M. 2014. Study on the antibacterial activity of Bergenia purpurascens extract. Afr J Tradit Complement Altern Med. 11:464–468.
   PubMedGoogle Scholar
• Sun M, Tang Y, Ding T, Liu M, Wang X. 2014. Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity. Fitoterapia. 92:1–8. DOI:10.1016/j.fitote.2013.10.004
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Stevens JC. 1992. The human hepatic cytochromes P450 involved in drug metabolism. Critical Rev in Toxicol. 22:1–21.
   PubMed Web of Science ®Google Scholar
• Yan Z, Caldwell GW. 2001. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. Curr Top Med Chem. 1:403–425.
   PubMedGoogle Scholar
• Zhang H, Ya G, Rui H. 2017. Inhibitory effects of triptolide on human liver cytochrome P450 enzymes and P-glycoprotein. Eur J Drug Metab Pharmacokinet. 42:89–98.
   PubMed Web of Science ®Google Scholar
• Zhang JW, Liu Y, Cheng J, Li W, Ma H, Liu HT, Sun J, Wang LM, He YQ, Wang Y, et al. 2007. Inhibition of human liver cytochrome P450 by star fruit juice. J Pharm Pharm Sci. 10:496–503.
   PubMed Web of Science ®Google Scholar
• Zhou S, Chan E, Li SC, Huang M, Chen X, Li X, Zhang Q, Paxton JW. 2004. Predicting pharmacokinetic herb-drug interactions. Drug Metab Drug Interac. 20:143–158.
   PubMedGoogle Scholar
• Zhou SF. 2008. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab. 9:310–322.
   PubMed Web of Science ®Google Scholar